EGFR and non-small cell lung carcinoma: Taken together, these findings strongly suggest that hypoxia regulates IGF1 expression through HIF1α, and that upregulated IGF1 induces the activation of IGF1R and increases the gefitinib-resistant CSCs in EGFR mutation-positive NSCLC cells under the hypoxia.